Home > Shareholding > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Total of Promoter and Promoter Group Shareholding

   Back to ShareHolding Pattern
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

Last 5 Year Total of Promoter and Promoter Group ShareHolding (%) History of BAFNA PHARMACEUTICALS

Last 8 Quarters
Mar2026Dec2025Sep2025Jun2025Mar2025Dec2024Sep2024Jun2024
75.00 %75.00 %75.00 %75.00 %75.00 %88.30 %88.30 %88.30 %

What is the latest Total of Promoter and Promoter Group Shareholding of BAFNA PHARMACEUTICALS ?

The latest Total of Promoter and Promoter Group ShareHolding in BAFNA PHARMACEUTICALS is 75.00 % based on Mar2026 results.
Year Total of Promoter and Promoter Group
Mar202675.00 %
Dec202575.00 %
Sep202575.00 %
Jun202575.00 %
Mar202575.00 %
Dec202488.30 %
Sep202488.30 %
Jun202488.30 %

How is Total of Promoter and Promoter Group Shareholding of BAFNA PHARMACEUTICALS Trending?

Years Total of Promoter and Promoter Group % Change
Mar2026 75.00 %
0.00
Dec2025 75.00 %
0.00
Sep2025 75.00 %
0.00
Jun2025 75.00 %
0.00
Mar2025 75.00 %
-15.06
Dec2024 88.30 %
0.00
Sep2024 88.30 %
0.00
Jun2024 88.30 % -

Compare Total of Promoter and Promoter Group ShareHolding of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹423.6 Cr 21.3% 18.6% 103.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,933.0 Cr -1.2% -2.3% 5.3% Stock Analytics
DIVIS LABORATORIES ₹175,833.0 Cr -1% -0.9% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,549.0 Cr -1.3% 1.4% 38.1% Stock Analytics
CIPLA ₹113,155.0 Cr -0.1% 4.8% -6.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,652.0 Cr -2.8% -0.3% 1.2% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

21.3%

18.6%

103.8%

SENSEX

-0.7%

-3.6%

-9.1%


You may also like the below Video Courses